Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Latest filing published 21 Oct 2022 for ONCODESIGN, €254k. Read the official filing
Filing timeline
BuySaleStephane GERART
Insider track record
Disclosed buys
2
Disclosed sells
1
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Stephane GERART: trading record in brief
Stephane GERART (senior executive) discloses dealings in Oncodesign to AMF. Over a trading history stretching from 7 October 2022 to 18 October 2022, the count stands at 3 filings.
The open-market side counts 2 purchases for €202k alongside 1 sale for €254k. Netting one side against the other leaves €53k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 21 October 2022 with an open-market sale (€254k) in Oncodesign. The last insider purchase was made public on 12 October 2022, 1,466 days ago. The median gap between a trade and its publication by AMF is 5 days. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from AMF. Past trades are no guide to future returns.
Companies and markets linked to Stephane GERART
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
17,640 shares@ €14.42100.0% of flowActionHors plateforme de négociationISIN FR00117662292022DD867548
10,080 shares@ €10.00100.0% of flowActionEuronext ParisISIN FR00117662292022DD866011
Canonical exit: 5 Jan 2023 (T+90)
2 of 2 declarations
